SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.350-11.2%Nov 13 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: xcentral1 who wrote (1830)3/8/2010 10:04:59 AM
From: donpat  Read Replies (2) of 12871
 
I'm really impressed and intrigued by this $40 million shelf financing.

It looks like it can put NNVC on the medical map and could well lead to some lucrative opportunities.

If the big pharma boys are impressed by cash, well, $40 million speaks loudly!

The one big pharma that we know a bit about is the EKC one and who it is in particular has never been officially disclosed but I think I know who it is. There are apparently others, too, interested at least and talking but about which cide and how close to a deal is not stated. This $40 million might get their attention, particularly when some of that might be required for some reason to get them fully involved. Eva Harris and Dengue are the latest venture and if cash is required to further that along then now it is available.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext